Search clinical trials for: Eylea

Total 283 results

Bayer

Completed

Study to Gather Information on the Safety and Use of Aflibercept Injections Into the Eye for the Treatment of Eye Disorders in Mexican Routine Clinical Practice (MAIA)

Retinal Disease

Mexico
Southeast Retina Center, Georgia

Completed

IAI for Persistent DME After Treatment With Bevacizumab And Ranibizumab (ROTATED)

Diabetic Macular Edema

United States
Celltrion

Completed

Study to Compare Efficacy and Safety of CT-P42 in Comparison With Eylea in Patients With Diabetic Macular Edema

Diabetic Macular Edema (DME)

Slovakia
Alteogen, Inc.

Completed

Clinical Study of ALT-L9 to Determine Safety, Efficacy and Pharmacokinetics in Neovascular AMD

Neovascular Age-related Macular Degeneration

Korea, Republic of
Mylan Pharmaceuticals Inc
Momenta Pharmaceuticals, Inc.

Completed

Comparative Study to Evaluate the Efficacy and Safety of MYL-1701P and Eylea® in Subjects With Diabetic Macular Edema (DME) (DME)

Diabetic Macular Edema

Japan, United States, Czechia, Germany, Hungary, India, Latvia, Poland, Russian Federation
Hadassah Medical Organization
Bayer

Unknown

Aflibercept (EYLEA)as Secondary or Third Line Treatment for Neovascular Age-related Macular Degeneration.

Neovascular Age-related Macular Degeneration

Israel
McMaster University

Active, not recruiting

Mean Visual Acuity Changes Following Five Injections of Aflibercept

Diabetic Macular Edema

Canada
Benha University

Recruiting

BEOVU Versus Eylea in the Treatment of Age-related Macular Neovascular Degeneration

Macula Lutea Degeneration

United Arab Emirates
Seoul National University Hospital

Completed

Visual Function Change in Wet Age-related Macular Degeneration Patients With Better Baseline Visual Acuity

Age-Related Macular Degeneration

Korea, Republic of
Indonesia University
Bayer

Completed

Early Anatomical, Physiological, and Clinical Changes in Diabetic Macular Edema After Intravitreal Aflibercept Injection

Diabetic Retinopathy | Diabetic Macular Edema | Clinically Significant Macular Edema

Indonesia
St. Erik Eye Hospital

Unknown

Eylea and Lucentis for Macular Edema in Branch Retinal Vein Occlusion

Branch Retinal Vein Occlusion With Macular Edema

Sweden
Mylan Pharmaceuticals Inc
Momenta Pharmaceuticals, Inc.

Completed

Extension Study of MYL-1701P-3001 for Safety and Efficacy

Diabetic Macular Edema

India
University of Athens

Completed

Intravitreal Aflibercept for Macular Edema Due to Central Retinal Vein Occlusion (INTRAMED-CRVO)

Retinal Vein Occlusion | Vascular Occlusive Disease
Sandoz

Completed

Phase III Study Assessing the Efficacy, Safety and Immunogenicity of SOK583A1 Versus Eylea® in Patients With Neovascular Age-related Macular Degeneration (Mylight)

Neovascular Age-related Macular Degeneration

United States, Bulgaria, Czechia, Australia, Austria, France, Germany, Hungary, Israel, Japan, Latvia, Lithuania, Poland, Portugal, Slovakia, Spain
Lawson Health Research Institute

Completed

Eylea to Treat Retinal Pigment Epithelial Detachment (RPED) Secondary to Wet Age-Related Macular Degeneration (wAMD)

Retinal Pigment Epithelial Detachment Secondary to Age-related Macular Degeneration

Canada
Faculty Hospital Kralovske Vinohrady

Withdrawn

Brolucizumab vs. Aflibercept for Retinal Angiomatous Proliferation (BEY-RAP)

Wet Macular Degeneration

Czechia
Bayer
Regeneron Pharmaceuticals

Recruiting

A Study to Learn How Well a Higher Amount of Aflibercept Given as an Injection Into the Eye Works and How Safe it is in People With Reduced Vision Due to Swelling in the Macula, Central Part of the Retina Caused by a Blocked Vein in the Retina (Macula Edema Secondary to Retinal Vein Occlusion) (QUASAR)

Macular Edema Secondary to Retinal Vein Occlusion

Korea, Republic of, Japan, China, Lithuania, United States, Italy, Spain, Hungary, Israel, Portugal, Serbia, Poland, United Kingdom, Thailand, Czechia, Austria, Turkey, Australia, Bulgaria, Estonia, France, Georgia, Germany, Latvia, Mal... and more
Bayer

Completed

A Study to Assess the Effectiveness of Aflibercept in Routine Clinical Practice in Patients With Diabetic Macular Oedema (DRAKO)

Macular Edema

United Kingdom
Uptown Eye Specialists

Not yet recruiting

Ozurdex in Suboptimal Diabetic Macular Edema Patients (DME)

Diabetic Macular Edema
Neurotech Pharmaceuticals

Terminated

Study of the Intravitreal Implantation of NT-503-3 Encapsulated Cell Technology (ECT) for the Treatment of Recurrent Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)

Macular Degeneration

United States, Israel
National Cancer Institute (NCI)

Completed

Belinostat in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

Advanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular Carcinoma

United States, Singapore
National Cancer Institute (NCI)

Completed

Belinostat (PXD101) to Treat Tumors of the Thymus at an Advanced Stage

Thymic Carcinoma | Thymoma

United States
Rophibio, Inc.

Not yet recruiting

A Phase 3 Clinical Trial to Compare RBS-001 to Eylea® in Subjects With Neovascular Age-Related Macular Degeneration

Neovascular Age-related Macular Degeneration (nAMD)

United States
University of Nebraska
Regeneron Pharmaceuticals

Completed

Pharmacokinetic Study of Intravitreal Aflibercept Injection in Eyes With Wet Age-related Macular Degeneration (DRAW)

Neovascular Macular Degeneration

United States
University Hospital Inselspital, Berne

Completed

Comparison of Treatment rOutine Using afLibERcept: Strict vs relAxed retreatmeNT Regimen

Age Related Macular Degeneration

Switzerland
Valley Retina Institute

Unknown

Evaluation of Treatment of High riSk proLiferative Diabetic retinopathY With Intravitreal Aflibercept injectioN (ELYSIAN)

Proliferative Diabetic Retinopathy
Charles C Wykoff, PhD, MD
Regeneron Pharmaceuticals

Completed

Intravitreal Aflibercept for Retinal Non-Perfusion in Proliferative Diabetic Retinopathy (RECOVERY)

Proliferative Diabetic Retinopathy

United States
Rabin Medical Center

Terminated

Subconjunctival Aflibercept (EYLEA®) for the Treatment of Corneal Neovascularization

Corneal Neovascularization

Israel
University Hospital, Bonn

Completed

Intravitreal Aflibercept for Therapy of Patients With Pseudoxanthoma Elasticum (PXE) (EyNeP)

Pseudoxanthoma Elasticum

Germany
Hadassah Medical Organization
Bayer

Completed

Multicenter Study to Evaluate the Efficacy of Treat and Extend Regimen of Aflibercept (EYLEA) as a Second Line Treatment for Diabetic Macular Edema

Diabetic Macular Edema (DME)
University of Colorado, Denver

Completed

Use of Intravitreal Aflibercept Injection for Neovascular Glaucoma

Neovascular Glaucoma

United States
Justis Ehlers
Regeneron Pharmaceuticals

Completed

Peripheral and Macular Retinal Vascular Perfusion and Leakage in DME and RVO (PERMEATE)

Central Retinal Vein Occlusion | Diabetic Macular Edema | Retinal Vein Occlusion | Branch Retinal Vein Occlusion

United States
Amy C Schefler, MD
Regeneron Pharmaceuticals

Unknown

Intravitreal Aflibercept Injection for Radiation Retinopathy Trial (ARRT)

Radiation Retinopathy

United States
Larkin Community Hospital

Completed

Role of Intravitreal Aflibercept Injection for the Treatment of Radiation Maculopathy

Adverse Effect of Radiation Therapy
Rishi Singh
Regeneron Pharmaceuticals

Completed

Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or Bevacizumab (SwapTwo)

Diabetic Retinopathy | Macular Edema

United States
Rishi Singh
Regeneron Pharmaceuticals

Completed

Prevention of Macular Edema In Patients With Diabetic Retinopathy Undergoing Cataract Surgery (PROMISE)

Diabetic Retinopathy

United States
Kamal Kishore, MD

Unknown

Intravitreal Aflibercept Injection for Symptomatic Macular Edema From Retinal Artery Macroaneurysms

Macular Edema | Retinal Artery Macroaneurysm

United States
Manhattan Eye, Ear & Throat Hospital
Northwell Health

Withdrawn

Intravitreal Aflibercept Injections In The Treatment Of Pattern Dystrophy (AVA)

Pattern Dystrophy of Macula

United States
The University of Hong Kong

Completed

Treatment of Recalcitrant Neovascular AMD Using Brolocizumab With Immediate T&E

Age-Related Macular Degeneration

Hong Kong
Wake Forest University Health Sciences

Terminated

Vascular Endothelial Growth Factor (VEGF) Levels in Retinal Vein Occlusion (RVO) During Anti-VEGF Treatment

Retinal Vein Occlusion

United States
Centre Hospitalier Intercommunal Creteil
Bayer

Completed

Aflibercept After Ranibizumab in Exudative Age-related Macular Degeneration (ARI2)

Eye Diseases | Macular Degeneration | Retinal Degeneration | Retinal Diseases | Wet Macular Degeneration

France
Stanford University
Regeneron Pharmaceuticals

Withdrawn

A Pharmacokinetic stuDy of intRavitreal Aflibercept Injection in Vitrectomized and Non-vitrectomized Eyes With Diabetic Macular Edema (DRAW-2)

Diabetic Macular Edema

United States
Clover Biopharmaceuticals AUS Pty Ltd

Withdrawn

Study of SCB-420 in Subjects With Neovascular Age-related Macular Degeneration

Wet Age-related Macular Degeneration
Mabwell (Shanghai) Bioscience Co., Ltd.

Completed

Safety and Efficacy of 9MW0813 in Subjects With Diabetic Macular Edema

Diabetic Macular Edema

China
Advanced Eye Research Associates

Active, not recruiting

Assessment of Biomarker Profile in Diabetic Macular Edema With Intravitreal Aflibercept Injection

Diabetic Macular Edema

United States
Taipei Veterans General Hospital, Taiwan
National Taiwan University Hospital; Chang Gung Memorial Hospital; Kaohsiung...

Completed

Efficacy and Safety of Aflibercept as Mono-therapy in Treat and Extend Regimen for DME Patients in Taiwan

Center-involved Diabetic Macular Edema
Greater Houston Retina Research
Regeneron Pharmaceuticals

Completed

Long-Term Efficacy & Safety of Aflibercept IVT for the Treatment of DME in Subjects Who Completed the VISTA-DME Trial

Diabetic Macular Edema

United States
Barcelona Macula Foundation
Bayer; TFS Trial Form Support

Completed

Study to Evaluate Efficacy of Aflibercept in Neovascular Age-related Macular Degeneration Patients Non Responders to Anti-Vascular Endothelial Growth Factor (MACBETH)

Wet Macular Degeneration

Spain
Maisonneuve-Rosemont Hospital
Bayer

Unknown

Effect of Aflibercept (Eylea®) in the Management of Bevacizumab (Avastin®) Resistant Diabetic Macular Edema (Eylea)

Diabetic Macular Edema

Canada
Tennessee Retina
Regeneron Pharmaceuticals

Unknown

On-label tReatment With Intravitreal Aflibercept injectiOn for Patients With Persistent Pigment epitheliaL Detachments in Neovascular Age Related Macular Degeneration (AMD) (ROLL)

Age Related Macular Degeneration | Pigment Epithelial Detachment

United States

Search clinical trials for: Eylea

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ecuador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations